Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.65 SEK | +9.14% | +44.00% | -10.84% |
Apr. 25 | Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 183M 16.71M | Sales 2025 * | 244M 22.34M | Capitalization | 2.05B 188M |
---|---|---|---|---|---|
Net income 2024 * | -37M -3.38M | Net income 2025 * | -12M -1.1M | EV / Sales 2024 * | 11.1 x |
Net cash position 2024 * | 23.8M 2.18M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.39 x |
P/E ratio 2024 * |
-33.2
x | P/E ratio 2025 * |
-59.8
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.5% |
Latest transcript on Sedana Medical AB
1 day | +9.14% | ||
1 week | +44.00% | ||
Current month | +28.98% | ||
1 month | +36.30% | ||
3 months | -1.57% | ||
6 months | +19.85% | ||
Current year | -10.84% |
Managers | Title | Age | Since |
---|---|---|---|
Johannes Doll
CEO | Chief Executive Officer | 43 | 21-09-30 |
Johan Spetz
DFI | Director of Finance/CFO | - | 22-04-03 |
Peter Fröberg
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hilde Furberg
BRD | Director/Board Member | 65 | 21-12-31 |
Director/Board Member | 49 | 20-05-18 | |
Claus Bjerre
CHM | Chairman | 53 | 21-05-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 20.65 | +9.14% | 502,248 |
24-04-25 | 18.92 | +29.95% | 1,243,460 |
24-04-24 | 14.56 | +1.68% | 517,587 |
24-04-23 | 14.32 | +1.99% | 388,010 |
24-04-22 | 14.04 | -2.09% | 131,255 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am EDT
More quotesEPS Revisions
- Stock Market
- Equities
- SEDANA Stock